NeuroSense Therapeutics Ltd. a company developing treatments for neurodegenerative diseases, announced the initiation of the third stage of a collaborative biomarker study with Massachusetts...
Medline announced today the launch of its Vascular Access Health Solution, a new central line-associated bloodstream infection (CLABSI) prevention solution driven by human factors-based...
Samsung Biologics (KRX: 207940.KS) announced that it has reached an agreement with Biogen for the buyout of Biogen's stake in the Samsung Bioepis joint...
Lupin Pharmaceuticals Inc., (Lupin), and Exeltis USA Inc. announced a promotional agreement for Exeltis to promote SOLOSEC® along with Exeltis' existing line of Women's...
